QIAGEN and ICMP to develop first NGS workflow for identification of missing persons

Collaboration targets “Sample to Insight” sequencing solutions to enhance research and applications in human identification

Hilden, Germany, and The Hague, The Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and the International Commission on Missing Persons (ICMP) today announced collaboration on a project to enhance ICMP’s ability to identify missing persons using next-generation sequencing (NGS) technologies. QIAGEN and ICMP will work together at the ICMP’s laboratory in The Hague to develop and validate a complete NGS solution, including QIAGEN’s “Sample to Insight” GeneReader NGS System* and other QIAGEN workflow solutions, as well as innovative forensic panels designed for identification of missing persons using single nucleotide polymorphisms (SNPs).

The joint efforts integrate QIAGEN’s “Sample to Insight” integrated GeneReader NGS workflow with ICMP’s on-going efforts to advance the science of human identification through a consultative process that includes th

< | >